• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无胸腺大鼠腹腔注射抗肿瘤药物的毒性

Toxicity of intraperitoneally administered antitumour drugs in athymic rats.

作者信息

Lindén C J

机构信息

Department of Lung Medicine, University Hospital, Lund, Sweden.

出版信息

In Vivo. 1989 Jul-Aug;3(4):259-62.

PMID:2519862
Abstract

The toxicity of eight anticancer drugs given intraperitoneally to athymic rats was investigated to define the maximum tolerable doses (MTD). Drugs were given once weekly. Toxicity was assessed as percentage loss of body weight (LBW%) or percentage toxic death rate (TDR%) during the first week after drug administration. LBW% and TDR% were significantly correlated, r = 0.58 p less than 0.00001. From the regression equation for the relationship between LBW% and TDR%, 10 percent TDR (LD10), usually regarded as equivalent to MTD in animals, was found to correspond to 14 percent LBW. From the individual regression equations for LBW% and dose for each of six drugs, MTDs were calculated to be as follows; doxorubicin 7 mg/kg, cyclophosphamide 100 mg/kg, mitomycin C 1.8 mg/kg, cisplatin 8 mg/kg, vindesine 0.8 mg/kg and vincristine 0.9 mg/kg. LD10 was found to be 40 mg/kg for both carmustine (BCNU) and etoposide.

摘要

研究了八种抗癌药物腹腔注射给无胸腺大鼠的毒性,以确定最大耐受剂量(MTD)。药物每周给药一次。毒性评估为给药后第一周体重减轻百分比(LBW%)或毒性死亡率百分比(TDR%)。LBW%与TDR%显著相关,r = 0.58,p小于0.00001。根据LBW%与TDR%关系的回归方程,通常在动物中被视为等同于MTD的10%TDR(LD10)被发现对应于14%LBW。根据六种药物各自的LBW%与剂量的个体回归方程,计算出的MTD如下:阿霉素7 mg/kg、环磷酰胺100 mg/kg、丝裂霉素C 1.8 mg/kg、顺铂8 mg/kg、长春地辛0.8 mg/kg和长春新碱0.9 mg/kg。卡莫司汀(BCNU)和依托泊苷的LD10均为40 mg/kg。

相似文献

1
Toxicity of intraperitoneally administered antitumour drugs in athymic rats.无胸腺大鼠腹腔注射抗肿瘤药物的毒性
In Vivo. 1989 Jul-Aug;3(4):259-62.
2
Chemosensitivity spectrum of a human pleural mesothelioma xenograft grown in athymic rats.在无胸腺大鼠体内生长的人胸膜间皮瘤异种移植瘤的化学敏感性谱。
In Vivo. 1991 Jul-Aug;5(4):375-80.
3
Response to doxorubicin and cyclophosphamide of a human pleural mesothelioma clinically and as a xenograft in nude rats.人胸膜间皮瘤对阿霉素和环磷酰胺的临床反应以及作为裸鼠异种移植瘤的反应。
In Vivo. 1990 Jan-Feb;4(1):55-9.
4
Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.脂质体包裹的顺铂经胸膜内给药治疗恶性胸腔积液患者的I期临床与药理学研究
Clin Cancer Res. 1997 Mar;3(3):373-9.
5
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.甲氨蝶呤 - 白蛋白每周静脉推注方案用于癌症患者的I期试验。德国癌症协会医学肿瘤学协会I期研究组
Clin Cancer Res. 1999 Apr;5(4):753-9.
6
Grouping of anticancer drugs based on administration method-related toxicity patterns in rats.基于大鼠给药方法相关毒性模式的抗癌药物分组。
Anticancer Res. 1997 Nov-Dec;17(6D):4611-4.
7
Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.新型癌症治疗药物早期临床试验的仅啮齿动物毒理学评估。
Br J Cancer. 1999 Nov;81(5):760-8. doi: 10.1038/sj.bjc.6690761.
8
Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.ZD1694(拓扑替康)在裸鼠模型中对人头颈癌的抗肿瘤活性:给药方案和血浆胸苷的作用
Clin Cancer Res. 1999 Jul;5(7):1925-34.
9
Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide.
Cancer Res. 1993 May 15;53(10 Suppl):2338-43.
10
Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.鞘内注射细胞毒性药物的毒性及其对大鼠脑膜癌病鞘内Walker 256癌肉瘤模型的抗肿瘤活性。
Cancer Res. 1989 Feb 15;49(4):977-82.

引用本文的文献

1
Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression.寡聚岩藻聚糖可抑制 IL-6 和 CCL2 的产生,并与 p53 合作抑制 ATM 信号通路和肿瘤进展。
Sci Rep. 2017 Sep 19;7(1):11864. doi: 10.1038/s41598-017-12111-1.
2
Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.低剂量依托泊苷联合溶瘤单纯疱疹病毒对人胶质母细胞瘤干细胞移植瘤的增效作用。
Clin Cancer Res. 2011 Dec 1;17(23):7383-93. doi: 10.1158/1078-0432.CCR-11-1762. Epub 2011 Oct 5.
3
In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy.
催化抗体-前药系统的体内活性:抗体催化依托泊苷前药活化用于选择性化疗。
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7528-33. doi: 10.1073/pnas.131187998. Epub 2001 Jun 12.